Bayesian borrowing

R&D

Innovative trial designs that harness data augmentation, RWD, and the power of AI are enabling a new era of rare disease research.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.